Adenoidectomy, Tonsillectomy
Conditions
Keywords
acetaminophen, pain, pediatric, intravenous, per os, flacc, paed
Brief summary
MetroHealth's main campus administers IV Tylenol as part of its pain management protocol for elective tonsillectomy/adenoidectomy, whereas Parma campus does not. Comparing these practices provides an opportunity to evaluate the benefits of IV Tylenol for pain, agitation, and associated secondary outcomes in this population. The pain/agitation would be assessed with a validated tool PAED and FLACC
Interventions
OTHERNo Intervention: Observational Cohort
No Intervention: Observational Cohort
Sponsors
MetroHealth Medical Center
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 8 Years
Healthy volunteers
No
Inclusion criteria
* Subjects pediatric patients aged ≤7 years, observed by study team who will complete the scales * Undergoing elective tonsillectomy and adenoidectomy.
Exclusion criteria
* Pre-existing neurological or developmental disorders impacting pain/agitation scores
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain Assessment | * "Baseline" * "Perioperative/Periprocedural" | Evaluate the impact of IV Acetaminophen on pain at emergence and in the Post-Anesthesia Care Unit (PACU) using a validated pediatric assessment tool, FLACC (Face, Legs, Activity, Cry, Consolable) Behavior Pain Assessment Tool. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Agitation Assessment | * "Baseline" * "Perioperative/Periprocedural" | Evaluate the impact of IV Tylenol on Agitation scores at emergence and in the Post-Anesthesia Care Unit (PACU) using a validated pediatric assessment tool, Pediatric Anesthesia Emergence Delirium (PAED) scale. |
Countries
United States
Outcome results
None listed